DATATRAK International, Inc. (DTRK) Research
DATATRAK International, Inc. delivers advanced technology and comprehensive service offerings tailored for the clinical research industry. Its flagship offering, DATATRAK ONE Unified Experience, is an integrated clinical enterprise platform empowering clinical professionals and service providers to efficiently design, execute, and oversee clinical trials. This robust suite features specialized modules such as UX CTMS 360 for trial planning and administration, UX Trial to streamline the design-to-deployment workflow, UX EDC & Medical Coding for secure data capture and delivery, and UX Randomization and Trial Supply Management for automating patient assignment and logistics. Further components include UX Patient Data Capture, UX Safety, and UX Training, which facilitates user education and certification tracking. Additionally, DATATRAK provides Clinical Consulting Services, offering expert training, ongoing support, a dedicated learning center, Software-as-a-Service hosting, adherence to industry standards, and bespoke trial design assistance. The company serves a diverse clientele, including contract research organizations, pharmaceutical and biotechnology firms, and medical device companies engaged in clinical studies. Founded in 1991, DATATRAK International, Inc. is headquartered in Mayfield Heights, Ohio.
Market snapshot
- Symbol
- DTRK
- Price
- $0.39
- Day change
- 0.00%
- Market cap
- $498.4K
- P/E ratio
- 3.90x
- 52-week range
- 0.19-1.63
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
Peer companies
Open DATATRAK International, Inc. (DTRK) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.